Research Report
A model across 35 sectors and a decade of data on which strategic behaviours preceded value creation — and why trajectory beats current position.
Research
Strategy and Growth
8 min read
25%
Average EV-to-EBIT ratio across the research base rose 25% between 2014 and 2024, from 14
84%
Built the foundation for surgical automation years before the rest of the industry caught on, focusing not on quarterly
20%
Index identifies Value Leaders as companies scoring in the top 20% within their sector (or the top 10% where an industry
The research is built on a model covering 1,300 publicly listed companies across 35 industry segments from 2014 to 2024, combining company-specific market research on strategic behaviours with market valuations sourced from S&P Global Capital IQ. Over that decade, $27 trillion in enterprise value changed hands — one of the largest redistributions of corporate worth in modern history.
The pace is what should concern an Australian board more than the total. Roughly a third of that decade's movement happened in the last two years alone, which the research calls the Age of AI: value migration has doubled in speed since 2022. A single year still looks like noise, but two years now move as much value as four used to.
The reshuffling is not cosmetic. One in five of today's largest companies by revenue weren't on that list a decade ago, and a quarter of the companies that led their sector on enterprise value in 2014 no longer hold that position. Leadership is earned, lost and rebuilt every cycle — and the research's central claim is that this cycle is no longer a fair fight between equals.
The companies the research identifies as Value Leaders — those that captured a disproportionate share of the decade's enterprise value gains — grew earnings at nearly 3x the pace of their peers, while their enterprise value expanded by more than 7x over the same period. That is not a modest edge compounding slowly; it is a structural separation.
The market itself has become more willing to pay for a credible growth story than for current results. The average EV-to-EBIT ratio across the research base rose 25% between 2014 and 2024, from 14.7 to 18.3 — investors are now pricing future potential more heavily than they were a decade ago, and rewarding companies that signal a believable path to future growth over those simply defending today's earnings.
The research estimates a further $2.4 trillion in earnings is at stake over the next decade as this battle continues. Consistent earnings growth remains the entry requirement, not the differentiator — the innovations of the recent past are already priced into today's valuations, which means the next decade's leaders will be decided by what they do next, not what they have already done.
Value Hunters monetise what they already have — customers, data, installed bases — rather than chasing entirely new markets, because the fastest growth is often hiding in plain sight.
There is no single formula for market leadership — the research found that the most highly valued companies excel in at least three of six identified characteristics, mixed according to what their specific industry rewards. Value Hunters monetise what they already have — customers, data, installed bases — rather than chasing entirely new markets, because the fastest growth is often hiding in plain sight. Outcome Evangelists sell measurable results instead of products or hours, tying pricing to outcomes and using that shift to deepen customer relationships and expand market share.
Commitment Builders pair deep relevance to a customer's core operations with durable, multi-year contracts and performance-based pricing, producing stable and predictable revenue streams. Active Portfolio Managers treat their own business like an investment portfolio — reallocating capital toward high-growth adjacencies, pruning underperforming segments and running early-stage concept tests before committing, rather than holding every line of business out of habit.
Efficiency Engineers turn operational constraints into competitive advantage, building AI-driven operations and supply chains that adapt to volatility instead of merely absorbing it. Innovation Accelerators treat innovation as a continuous discipline rather than an occasional project, industrialising how ideas move from concept to commercial deployment and shortening development cycles at scale. No company needs all six — but leaders in every sector the research studied were fluent in at least half of them.
In High Tech, $2.9 trillion in enterprise value shifted to the top 20 companies over the past decade — one of the largest concentrations the research measured across any sector — even though the sector as a whole carries one of the lowest EV-to-EBIT ratios analysed, at around 18x. The gap between those two facts is the story: markets still treat hardware cautiously by default, which means the leaders who broke out of that discount did so by changing what they were selling, not by selling more of the same thing.
Delta Electronics illustrates the slow-compounding path. A decade ago it was a mid-tier industrial supplier known for reliable power components. Rather than staying a parts vendor, it embedded its power and cooling systems directly into customers' long-planning-horizon infrastructure — telecom networks, cloud data centres, manufacturing lines — converting one-off equipment sales into multi-year supply agreements and repeat orders. It then expanded deliberately into data centre power, EV charging and factory automation, building modular systems that extend equipment life and lower total cost for customers. The result was a decade of quiet, steady outperformance rather than a single dramatic re-rating.
F5 Networks took the opposite route: well-timed reinvention rather than steady compounding. Long before the AI boom, F5 had already shifted from selling hardware boxes to software subscriptions — a move that took years to pay off but positioned it precisely when AI workloads created sudden demand for fast, secure data delivery as a service rather than a product. Because F5 kept costs and pricing disciplined through the transition, most of the AI-driven growth dropped straight through to earnings — a level of margin control few hardware companies manage mid-pivot. The research projects High Tech needs 4.4x today's earnings growth over the next decade just to keep pace with the value migration of the last one.
MedTech shows the inverse pattern to High Tech. $769 billion in enterprise value migrated to the top 30 companies over the decade, and the sector carries one of the highest average EV-to-EBIT ratios the research measured, at around 30x — markets already price MedTech generously, so leaders in this sector separated themselves by justifying that premium rather than overcoming a discount. Because the sector starts from a position of market confidence, the research projects it needs only 1.02x today's earnings growth to keep pace over the next decade — the gap to defend is smaller, but the premium is also easier to lose.
Boston Scientific's decade was defined by deliberate reinvention through active portfolio management. Ten years ago it was a steady but slower-growing player; rather than settling for incremental gains, it acquired faster-growing adjacent businesses — including Axonics, Silk Road and Intera Oncology — while pruning legacy exposure, shifting its centre of gravity toward electrophysiology, structural heart and interventional oncology, fields now driving double-digit organic growth. It paired that reallocation with rigorous clinical trials that made its cardiac platforms the safety and efficacy standard in their categories, then from 2022 accelerated further, launching roughly 100 new products in a single year using digital simulation and AI-enabled procedural planning.
Intuitive Surgical shows what a decade of that same discipline compounds into. It built the foundation for surgical automation years before the rest of the industry caught on, focusing not on quarterly growth but on a self-reinforcing ecosystem of hardware, instruments, training and analytics — and by 2024 that patience had produced 84% recurring revenue, a figure few MedTech companies can approach. Its da Vinci 5 platform, running on a 10,000x leap in compute capacity, and its Case Insights analytics turned surgical precision into a subscription-like relationship: leasing models, multi-year service contracts and deep training programs made the company part of hospital infrastructure rather than another vendor, delivering 16% higher enterprise value growth and 7% higher earnings growth in the last two years than in the decade before it.
The index identifies Value Leaders as companies scoring in the top 20% within their sector (or the top 10% where an industry has fewer than 50 companies), weighted across three dimensions: trajectory over the full decade (20% of the score), acceleration during the 2023–24 AI boom specifically (60% — the heaviest weighting by design), and current market position measured by EV-to-EBIT ratio (20%). The heavy weighting on recent acceleration is deliberate: the research treats the last two years as the clearest signal of who is capitalising on the current shift, not merely who arrived with the largest historical lead.
For Australian businesses the sector-relative framing is the important part. Many Australian industries are concentrated, with a small number of large players, so absolute comparison against global peers misleads in both directions — flattering in scale terms, punishing in growth terms. The more useful question the research supports asking locally is sector-relative: within Australian banking, mining services, or health, who is behaving like a Value Hunter or a Commitment Builder right now, and is that the company gaining share of a shrinking pool of future-focused capital?
Neither Delta Electronics nor F5 Networks nor Boston Scientific led their industries a decade ago. All three earned the position through specific, sustained behavioural choices the model can identify years before the enterprise-value gap becomes visible on a scoreboard — which is precisely the gap Factor's resilience research addresses from the operating-model side.
The research, drawn from 850 senior executives surveyed globally between April and May 2025 alongside 18 in-depth interviews, converts into a four-step exercise any Australian leadership team can run at an offsite. Start by knowing your starting point: where is growth hiding in plain sight within your existing customer base, data and intellectual property, and what does your organisation already do well that it has stopped treating as an asset?
Then find what your specific market actually values — which of the six Value Leader characteristics are rewarded in your industry, what value expectations are rising fastest, and where is the value potential genuinely underexploited rather than merely underpriced? Choose an inspiration deliberately: which Value Leader, in Australia or globally, is most like your organisation in starting position, and what could you credibly imitate rather than admire from a distance?
Finally, get expansive: when did you last kill a major initiative and redeploy the resources rather than let it run on inertia, are you optimising for cost or engineering for future growth, and where specifically could AI accelerate a capability you already have rather than create an entirely new one? Judge yourself on trajectory as well as position — trajectory carries three times the index weighting of current standing precisely because current standing is a lagging measure. Explore Factor's research library or join a Factor executive event to pressure-test the answers with Australian peers navigating the same migration.
